Trials / Recruiting
RecruitingNCT07103382
Efficacy and Safety of Attapulgite in Patients With Obesity: An Exploratory Clinical Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Second Xiangya Hospital of Central South University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
To explore the safety and efficacy of attapulgite in the treatment of obese individuals or overweight/obese individuals with type 2 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Attapulgite | Participants were administered daily attapulgite (2.5 g) for a duration of 12 weeks. |
| DIETARY_SUPPLEMENT | Placebo | Participants were administered daily maltodextrin (2.5 g) for a duration of 12 weeks. |
Timeline
- Start date
- 2025-06-26
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2025-08-05
- Last updated
- 2025-09-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07103382. Inclusion in this directory is not an endorsement.